BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,775,878 | +29.1% | 126,803 | +28.2% | 0.04% | +12.5% |
| Q2 2023 | $10,674,277 | +63.8% | 98,900 | +89.1% | 0.03% | +128.6% |
| Q1 2023 | $6,515,011 | -50.1% | 52,300 | -39.9% | 0.01% | -62.2% |
| Q4 2022 | $13,069,140 | +43.3% | 87,000 | +28.7% | 0.04% | +37.0% |
| Q3 2022 | $9,119,000 | -23.0% | 67,600 | -14.9% | 0.03% | -28.9% |
| Q2 2022 | $11,839,000 | -36.3% | 79,400 | -27.2% | 0.04% | -36.7% |
| Q1 2022 | $18,591,000 | +62.4% | 109,000 | +145.5% | 0.06% | +62.2% |
| Q4 2021 | $11,447,000 | +3.3% | 44,400 | +9.4% | 0.04% | -7.5% |
| Q3 2021 | $11,084,000 | +24.1% | 40,600 | +1.8% | 0.04% | +14.3% |
| Q2 2021 | $8,933,000 | +501.5% | 39,900 | +193.4% | 0.04% | +400.0% |
| Q1 2021 | $1,485,000 | +421.1% | 13,600 | +288.6% | 0.01% | +600.0% |
| Q4 2020 | $285,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |